Literature DB >> 24897946

Conditioned pain modulation in temporomandibular disorders (TMD) pain patients.

Yuka Oono1, Kelun Wang, Lene Baad-Hansen, Simple Futarmal, Hikaru Kohase, Peter Svensson, Lars Arendt-Nielsen.   

Abstract

The aims were to investigate (1) if temporomandibular disorders (TMD) patients with temporomandibular joint (TMJ) pain had different conditioned pain modulation (CPM) compared with healthy subjects and, (2) if clinical pain characteristics influenced CPM. Sixteen TMD pain patients and 16 age-matched healthy subjects were participated. A mechanical conditioning stimulus (CS) was applied to pericranial muscles provoking a pain intensity of 5/10 on a visual analogue scale. Pressure pain thresholds (PPT) and pressure pain tolerance thresholds (PPTol) were assessed at masseter, forearm and painful TMJ (only PPT) before, during, and 20 min after CS. Data were analyzed with ANOVAs. The correlations between CPM effect and ratings of TMD pain intensity on a numerical rating scale (NRS) or the pain duration were calculated (correlation coefficient; R). The relative PPT and PPTol increases (mean for the three assessment sites) during CS were significantly higher than baseline in healthy subjects (43.0 ± 3.6, 33.0 ± 4.0 %; P < 0.001, P < 0.001) but not in the TMD pain patients (4.9 ± 2.7, -1.4 ± 4.1 %; P = 0.492, P = 1.000) with significant differences between groups (P < 0.001). In the patients, the relative PPT changes during CS were not significantly higher than baseline at TMJ (5.3 ± 3.8 %, P = 0.981) and masseter (-2.8 ± 4.8 %, P = 1.000) but significantly higher at forearm (12.3 ± 4.7 %, P = 0.039). No correlation was detected between TMD pain intensity and CPM effect (R = -0.261; P = 0.337) or between pain duration and CPM effect (R = -0.423; P = 0.103) at painful TMJ. These findings indicate that CPM is impaired in TMD pain patients especially at sites with chronic pain but not at pain-free sites and that the clinical pain characteristics do not influence CPM.

Entities:  

Mesh:

Year:  2014        PMID: 24897946     DOI: 10.1007/s00221-014-3997-7

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  33 in total

Review 1.  The whole body receptive field of dorsal horn multireceptive neurones.

Authors:  Daniel Le Bars
Journal:  Brain Res Brain Res Rev       Date:  2002-10

2.  Phenylephrine suppresses the pain modulation of diffuse noxious inhibitory control in rats.

Authors:  Kenzo Makino; Hikaru Kohase; Tatsuo Sanada; Masahiro Umino
Journal:  Anesth Analg       Date:  2010-04-01       Impact factor: 5.108

3.  Conditioned pain modulation evoked by different intensities of mechanical stimuli applied to the craniofacial region in healthy men and women.

Authors:  Yuka Oono; Kelun Wang; Peter Svensson; Lars Arendt-Nielsen
Journal:  J Orofac Pain       Date:  2011

4.  Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values.

Authors:  R Rolke; R Baron; C Maier; T R Tölle; - D R Treede; A Beyer; A Binder; N Birbaumer; F Birklein; I C Bötefür; S Braune; H Flor; V Huge; R Klug; G B Landwehrmeyer; W Magerl; C Maihöfner; C Rolko; C Schaub; A Scherens; T Sprenger; M Valet; B Wasserka
Journal:  Pain       Date:  2006-05-11       Impact factor: 6.961

Review 5.  Guidelines and recommendations for assessment of somatosensory function in oro-facial pain conditions--a taskforce report.

Authors:  P Svensson; L Baad-Hansen; M Pigg; T List; E Eliav; D Ettlin; A Michelotti; Y Tsukiyama; Y Matsuka; S K Jääskeläinen; G Essick; J D Greenspan; M Drangsholt
Journal:  J Oral Rehabil       Date:  2011-01-17       Impact factor: 3.837

6.  Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.

Authors:  Smriti Iyengar; Amy A Webster; Susan K Hemrick-Luecke; Jimmy Yu Xu; Rosa Maria A Simmons
Journal:  J Pharmacol Exp Ther       Date:  2004-07-13       Impact factor: 4.030

7.  Effects of alpha-adrenergic agonists on pain modulation in diffuse noxious inhibitory control.

Authors:  Tatsuo Sanada; Hikaru Kohase; Kenzo Makino; Masahiro Umino
Journal:  J Med Dent Sci       Date:  2009-03

8.  Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat.

Authors:  Daniel Le Bars; Anthony H Dickenson; Jean-Marie Besson
Journal:  Pain       Date:  1979-06       Impact factor: 6.961

9.  Somatosensory function following painful repetitive electrical stimulation of the human temporomandibular joint and skin.

Authors:  E E Ayesh; T S Jensen; P Svensson
Journal:  Exp Brain Res       Date:  2006-12-05       Impact factor: 2.064

10.  Effects of remote cutaneous pain on trigeminal laser-evoked potentials in migraine patients.

Authors:  Marina de Tommaso; Olimpia Difruscolo; Michele Sardaro; Giuseppe Libro; Carla Pecoraro; Claudia Serpino; Paolo Lamberti; Paolo Livrea
Journal:  J Headache Pain       Date:  2007-06-11       Impact factor: 7.277

View more
  12 in total

1.  Influence of self-reported physical activity and sleep quality on conditioned pain modulation in the orofacial region.

Authors:  Leticia Soares Fiedler; Laila Aguiar Machado; Yuri Martins Costa; Paulo César Rodrigues Conti; Leonardo Rigoldi Bonjardim
Journal:  Clin Oral Investig       Date:  2020-07-09       Impact factor: 3.573

2.  Clinical variables associated with the presence of articular pain in patients with temporomandibular joint clicking.

Authors:  Rodrigo Lorenzi Poluha; Giancarlo De la Torre Canales; Leonardo Rigoldi Bonjardim; Paulo César Rodrigues Conti
Journal:  Clin Oral Investig       Date:  2020-11-12       Impact factor: 3.573

3.  Inhibition of temporomandibular joint input to medullary dorsal horn neurons by 5HT3 receptor antagonist in female rats.

Authors:  K Okamoto; A Katagiri; M Rahman; R Thompson; D A Bereiter
Journal:  Neuroscience       Date:  2015-04-23       Impact factor: 3.590

Review 4.  Pain Modulation: From Conditioned Pain Modulation to Placebo and Nocebo Effects in Experimental and Clinical Pain.

Authors:  Janie Damien; Luana Colloca; Carmen-Édith Bellei-Rodriguez; Serge Marchand
Journal:  Int Rev Neurobiol       Date:  2018-08-14       Impact factor: 3.230

5.  Effects of acute mental stress on conditioned pain modulation in temporomandibular disorders patients and healthy individuals.

Authors:  Dyna Mara Araújo Oliveira Ferreira; Yuri Martins Costa; Leonardo Rigoldi Bonjardim; Paulo César Rodrigues Conti
Journal:  J Appl Oral Sci       Date:  2021-06-04       Impact factor: 2.698

6.  Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain.

Authors:  Kelsey M Nation; Milena De Felice; Pablo I Hernandez; David W Dodick; Volker Neugebauer; Edita Navratilova; Frank Porreca
Journal:  Pain       Date:  2018-05       Impact factor: 7.926

7.  Development and Characterization of An Injury-free Model of Functional Pain in Rats by Exposure to Red Light.

Authors:  Rajesh Khanna; Amol Patwardhan; Xiaofang Yang; Wennan Li; Song Cai; Yingshi Ji; Lindsey A Chew; Angie Dorame; Shreya S Bellampalli; Ryan W Schmoll; Janalee Gordon; Aubin Moutal; Todd W Vanderah; Frank Porreca; Mohab M Ibrahim
Journal:  J Pain       Date:  2019-05-02       Impact factor: 5.383

8.  Somatosensory abnormalities in Chinese patients with painful temporomandibular disorders.

Authors:  Guangju Yang; Lene Baad-Hansen; Kelun Wang; Kaiyuan Fu; Qiu-Fei Xie; Peter Svensson
Journal:  J Headache Pain       Date:  2016-04-12       Impact factor: 7.277

9.  Pain profiling of patients with temporomandibular joint arthralgia and osteoarthritis diagnosed with different imaging techniques.

Authors:  Simple Futarmal Kothari; Lene Baad-Hansen; Lars Bolvig Hansen; Niels Bang; Leif Hovgaard Sørensen; Helle Wulf Eskildsen; Peter Svensson
Journal:  J Headache Pain       Date:  2016-06-27       Impact factor: 7.277

Review 10.  Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions.

Authors:  Alfonso Gil-Martínez; Alba Paris-Alemany; Ibai López-de-Uralde-Villanueva; Roy La Touche
Journal:  J Pain Res       Date:  2018-03-16       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.